Actionable news
All posts from Actionable news
Actionable news in REGN: Regeneron Pharmaceuticals, Inc.,

Why Regeneron is Slumping

Shares of Regeneron Pharmaceuticals (REGN) are tanking this morning after Sanofi (SNY) released earnings that included disappointing sales of eczema drug Dupixent.

Illustration: Pixabay

Many of the headlines this morning have focused on Sanofi's upbeat take on the launch of Dupixent, which it shares with Regeneron. The market, however, is feeling less optimistic, as sales of Dupixent were slightly lower than the Street had been modeling.

Piper Jaffray's Edward Tenthoff and...